ADC Therapeutics SA - ADCT

Ownership (Schedule 13D / 13G) · latest 50 filings · Back to all files
Visible: 0
Filed Form Reporting person Percent Shares SEC
Aug 14, 2026 SCHEDULE 13G Nantahala Capital Management, LLC 9.69% 12,326,184 View
Aug 14, 2026 SCHEDULE 13G Wilmot B. Harkey 9.69% 12,326,184 View
Aug 14, 2026 SCHEDULE 13G Daniel Mack 9.69% 12,326,184 View
Apr 24, 2026 SCHEDULE 13G/A Redmile Group, LLC 9.9% 12,717,487 View
Apr 24, 2026 SCHEDULE 13G/A Jeremy C. Green 9.9% 12,717,487 View
Apr 24, 2026 SCHEDULE 13G/A RedCo II Offshore SPV LLC 6.1% 7,780,431 View
Apr 24, 2026 SCHEDULE 13G/A RedCo II Master Fund, L.P. 0.0% 0 View
Apr 06, 2026 SCHEDULE 13G/A Redmile Group, LLC 9.9% 12,692,841 View
Apr 06, 2026 SCHEDULE 13G/A Jeremy C. Green 9.9% 12,692,841 View
Apr 06, 2026 SCHEDULE 13G/A RedCo II Master Fund, L.P. 8.1% 10,276,407 View
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G. Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F). Amendments (/A) can repeat the same holder over time, so rows should not be summed. Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.